Viridian Therapeutics, Inc.\DE - Common Stock (VRDN)

CUSIP: 92790C104

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
101,911,273
Total 13F shares
23,259,955
Share change
+5,484,883
Total reported value
$459,848,025
Price per share
$19.77
Number of holders
52
Value change
+$113,447,608
Number of buys
35
Number of sells
9

Security key

92790C104

Report period

Q4 2021

Institutions

52

Top holders

10

Top shareholders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FRAZIER MANAGEMENT LLC
13F
Company
1.5%
1,505,200
$24,761,000 30 Sep 2021
13F
Logos Global Management LP
13F
Company
1.5%
1,500,000
$24,675,000 30 Sep 2021
13F
PERCEPTIVE ADVISORS LLC
13F
Company
1.4%
1,423,000
$23,408,000 30 Sep 2021
13F
Vivo Capital, LLC
13F
Company
1.3%
1,300,000
$21,385,000 30 Sep 2021
13F
Fairmount Funds Management LLC
13F
Company
0.93%
944,092
$15,530,000 30 Sep 2021
13F
Ally Bridge Group (NY) LLC
13F
Company
0.89%
904,978
$14,887,000 30 Sep 2021
13F
BVF INC/IL
13F
Company
0.79%
804,126
$13,228,000 30 Sep 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.71%
720,530
$11,853,000 30 Sep 2021
13F
Commodore Capital LP
13F
Company
0.66%
667,674
$10,983,000 30 Sep 2021
13F
Point72 Asset Management, L.P.
13F
Company
0.6%
610,000
$10,035,000 30 Sep 2021
13F
FRANKLIN RESOURCES INC
13F
Company
0.59%
600,000
$9,870,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
0.45%
461,912
$7,599,000 30 Sep 2021
13F
Ghost Tree Capital, LLC
13F
Company
0.34%
350,000
$5,758,000 30 Sep 2021
13F
Cormorant Asset Management, LP
13F
Company
0.34%
342,562
$5,635,000 30 Sep 2021
13F
Atlas Venture Advisors, Inc.
13F
Company
0.21%
209,505
$3,446,000 30 Sep 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.16%
161,345
$2,654,000 30 Sep 2021
13F
Eversept Partners, LP
13F
Company
0.16%
160,000
$2,632,000 30 Sep 2021
13F
Maven Securities LTD
13F
Company
0.14%
140,000
$2,297,000 30 Sep 2021
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.13%
135,807
$2,234,000 30 Sep 2021
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.1%
106,078
$1,745,000 30 Sep 2021
13F
Marshall Wace North America L.P.
13F
Company
0.07%
75,000
$1,234,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.06%
61,250
$1,007,000 30 Sep 2021
13F
Polar Asset Management Partners Inc.
13F
Company
0.06%
59,700
$982,000 30 Sep 2021
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.06%
58,096
$956,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
0.05%
50,841
$836,000 30 Sep 2021
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.05%
50,000
$823,000 30 Sep 2021
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.04%
44,000
$724,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
0.03%
34,651
$570,000 30 Sep 2021
13F
LMR Partners LLP
13F
Company
0.03%
33,508
$551,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
0.02%
23,841
$392,000 30 Sep 2021
13F
Walleye Capital LLC
13F
Company
0.02%
22,501
$370,000 30 Sep 2021
13F
Venrock Adviser, LLC
13F
Company
0.02%
19,495
$321,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
0.01%
9,915
$163,000 30 Sep 2021
13F
Walleye Trading LLC
13F
Company
0.01%
7,500
$123,000 30 Sep 2021
13F
UBS Group AG
13F
Company
0%
1,430
$24,000 30 Sep 2021
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
0%
1,034
$17,000 30 Sep 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
412
$7,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
173
$3,000 30 Sep 2021
13F
Frazier Life Sciences Public Fund, L.P.
3/4/5
10%+ Owner
class O/S missing
1,505,200
$31,609,200 23 Sep 2021

Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) as of Q4 2021

As of 31 Dec 2021, Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,259,955 shares. The largest 10 holders included BVF INC/IL, VR Adviser, LLC, FRAZIER MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Deep Track Capital, LP, TCG Crossover Management, LLC, Vivo Capital, LLC, Avidity Partners Management LP, Paradigm Biocapital Advisors LP, and Fairmount Funds Management LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
38
Q4 2021 holders
52
Holder diff
14
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .